Section 37, National Medical Commission Act, 2019 [S29-GKW]
As at 7 September 2026. In force from 1 December 2019 by S.O. 2200(E) [N12-K1F].
37. Appeal.—(1) Any person aggrieved by an order of the Licensing Authority under this Act may, within fifteen days from the date on which the order is communicated to him, prefer an appeal to the Drugs Controller in such form and accompanied by such fee as may be prescribed. (2) The appellate authority may, after giving the appellant an opportunity of being heard, confirm, modify or set aside the order appealed against. (3) No appeal shall lie under this section against an order made with the consent of the parties.
Defined terms in this text (2)
drug: Section 2, National Medical Commission Act, 2019 [S29FG9] (In this Act, unless the context otherwise requires,—): "drug" includes all medicines for internal or external use of human beings or animals and all substances intended to be used for or in the diagnosis, treatment, mitigation or prevention of any disease or disorder in human beings or animals
drug: 19 more definitions.
Licensing Authority: Section 2, National Medical Commission Act, 2019 [S29FG9] (In this Act, unless the context otherwise requires,—): "Licensing Authority" means the authority appointed under section 4 to grant licences under this Act
Licensing Authority: 21 more definitions.
Made under this section, or naming it (0)
none
Cited by (2)
Section 40, National Medical Commission Act, 2019 [S29-GPP], 25 September 2019, Band A. "section 37".
Rule 9, National Medical Commission Act Rules, 2020 [S29-WP3], 24 March 2020, Band A. "section 37 of the Act".
Not held (0)
none
Duties published under this section (0)
none